A world-class specialty pharmaceutical company
Our ambition is to become a leading specialty pharmaceutical company meeting the needs of patients around the world. With our broad portfolio of marketed and development-stage respiratory products we’re making good progress towards achieving our goal.
Press Releases
-
Circassia Receives Innovative Technology Contract from Vizient, Inc. for NIOX VERO® Asthma Management Products
-
Circassia Announces Tudorza® Successfully Met Both Primary Endpoints in ASCENT Phase IV Study in Chronic Obstructive Pulmonary Disease
-
Circassia Welcomes New NICE Guidelines Recommending Use of FeNO Testing in Asthma Diagnosis
